William Skelly
Director/Board Member at ACURA PHARMACEUTICALS, INC.
Net worth: - $ as of 2023-12-30
Profile
William G.
Skelly is currently the Chairman, President & Chief Executive Officer at Central Biomedia, Inc. and SERA, Inc. He is also an Independent Director at Acura Pharmaceuticals, Inc. Previously, he served as the President of Martec Pharmaceutical, Inc. from 1985 to 1990.
Skelly completed his undergraduate degree at Michigan State University and holds an MBA from the University of Missouri-Kansas City.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-01-01 | 575,989 ( 0.87% ) | - $ | 2023-12-30 |
William Skelly active positions
Companies | Position | Start |
---|---|---|
ACURA PHARMACEUTICALS, INC. | Director/Board Member | 2000-05-31 |
SERA, Inc. | Chief Executive Officer | 1989-12-31 |
Central Biomedia, Inc.
Central Biomedia, Inc. BiotechnologyHealth Technology Central Biomedia, Inc. manufactures private-labeled animal serum. The private company is based in Lamar, MO and has subsidiaries in United States. William G. Skelly has been the CEO of the company since 1990. | Chief Executive Officer | 1989-12-31 |
Former positions of William Skelly
Companies | Position | End |
---|---|---|
Martec Pharmaceutical, Inc. | President | 1989-12-31 |
Training of William Skelly
Michigan State University | Undergraduate Degree |
University of Missouri-Kansas City | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ACURA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Central Biomedia, Inc.
Central Biomedia, Inc. BiotechnologyHealth Technology Central Biomedia, Inc. manufactures private-labeled animal serum. The private company is based in Lamar, MO and has subsidiaries in United States. William G. Skelly has been the CEO of the company since 1990. | Health Technology |
SERA, Inc. | |
Martec Pharmaceutical, Inc. |
- Stock Market
- Insiders
- William Skelly